Successful Treatment of Nephrotic Syndrome Due To Fmf Amyloidosis With Azathioprine: Report of Three Turkish Cases
dc.authorid | Reha, Erkoc/0009-0001-7230-8843 | |
dc.authorid | Sayarlioglu, Mehmet/0000-0001-6214-1974 | |
dc.authorscopusid | 55911844200 | |
dc.authorscopusid | 8409430500 | |
dc.authorscopusid | 6602520064 | |
dc.authorscopusid | 23666715400 | |
dc.authorscopusid | 13105952900 | |
dc.contributor.author | Sayarlioglu, Hayriye | |
dc.contributor.author | Erkoc, Reba | |
dc.contributor.author | Sayarliogin, Mehmet | |
dc.contributor.author | Dogan, Ekrem | |
dc.contributor.author | Soyoral, Yasemin | |
dc.date.accessioned | 2025-05-10T17:07:27Z | |
dc.date.available | 2025-05-10T17:07:27Z | |
dc.date.issued | 2006 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | Sutcu Imam Univ, Fac Med, Dept Internal Med, Div Nephrol, TR-46050 Kahramanmaras, Turkey; Yuzuncu Yil Univ, Fac Med, Div Nephrol, Dept Internal Med, Van, Turkey | en_US |
dc.description | Reha, Erkoc/0009-0001-7230-8843; Sayarlioglu, Mehmet/0000-0001-6214-1974 | en_US |
dc.description.abstract | Secondary amyloidosis is a well-known complication of certain familial Mediterranean fever (FMF). We presented three Turkish patients with FMF and biopsy proven amyloidosis. These patients were treated with colchicine 1.5 mg/day. They have experienced five to six peritonitis attacks with fever within 1 year. On admission, the laboratory test results were as follows: serum creatinine 2.3, 0.6, and 0.5 mg/dl; albumin 4.2, 1.9, and 1.8 g/dl; and urinary protein excretion 4, 15, and 10 g/day, respectively. All the patients were started azathioprine (AZA) 100 mg/day and attacks were completely stopped. Laboratory findings were as follows after I year of AZA treatment: serum creatinine 1, 0.8, and 0.6 mg/dl; albumin 4.3, 3, and 3.5 g/dl; and urinary protein excretion 3, 8, and 1.5 g/day, respectively. Treatment with azathioprine in addition to colchicine could ameliorate the nephrotic syndrome and control the attacks very effectively in these cases. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1007/s00296-006-0188-2 | |
dc.identifier.endpage | 199 | en_US |
dc.identifier.issn | 0172-8172 | |
dc.identifier.issn | 1437-160X | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 16944160 | |
dc.identifier.scopus | 2-s2.0-33846114183 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 197 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00296-006-0188-2 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/6776 | |
dc.identifier.volume | 27 | en_US |
dc.identifier.wos | WOS:000243226400015 | |
dc.identifier.wosquality | Q2 | |
dc.language.iso | en | en_US |
dc.publisher | Springer Heidelberg | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Fmf | en_US |
dc.subject | Secondary Amyloidosis | en_US |
dc.subject | Azathioprine | en_US |
dc.title | Successful Treatment of Nephrotic Syndrome Due To Fmf Amyloidosis With Azathioprine: Report of Three Turkish Cases | en_US |
dc.type | Article | en_US |